Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma I: Introduction

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps.

Allergy·2026

Same author

EUFOREA summit in Brussels 2025: inspiring the future of allergy and respiratory care.

Frontiers in allergy·2026

Same author

The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways-An EAACI Position Paper.

Allergy·2026

Same author

Otitis Media With Effusion (OME) and Eustachian Tube Dysfunction: The Role of Allergy and Immunity-An EAACI Position Paper.

Allergy·2025

Same author

Reply to Correspondence: The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.

Allergy·2025

Same author

The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.

Allergy·2024

Same journal

Deficiency of Mitochondrial Fatty Acid Enzyme, CPT1A, Underlies Airway Epithelial Barrier Dysfunction in Severe Asthma.

Allergy·2026

Same journal

Surgical Management of Non-Allergic Rhinitis-An EAACI Task Force Position Paper.

Allergy·2026

Same journal

Real-World Evaluation of AI-Assisted Readout of Skin Prick Automated Test Results.

Allergy·2026

Same journal

Serotonin Degradation and Lipid Metabolism Regulate Human Tc2 Cell Effector Functions.

Allergy·2026

Same journal

Protein Corona-Coated Crystal Silica From Sandstorms Amplifies Allergic Rhinitis by Regulating Epithelial Integrity in Mice and Human Nasal Epithelia.

Allergy·2026

Same journal

EAACI Guidelines on Environmental Science for Allergy and Asthma-Evidence-Based Recommendations for Prevention and Public Health Action to Mitigate the Impact of Pollen Exposure on Respiratory Allergy.

Allergy·2026

See all related articles

Search research articles

Related Experiment Videos

Untangling asthma phenotypes and endotypes.

I Agache¹, C Akdis, M Jutel

¹Department of Allergy and Clinical Immunology, Faculty of Medicine, Transylvania University, Brasov, Romania. ibrumaru@unitbv.ro

|May 19, 2012

Summary

This summary is machine-generated.

Understanding asthma endotypes is crucial for personalized medicine. Identifying molecular biomarkers linked to asthma phenotypes can predict disease progression and treatment response, improving clinical practice.

Related Experiment Videos

Area of Science:

Pulmonology and Respiratory Medicine
Translational Medicine
Biomarker Discovery

Background:

Asthma is a complex respiratory disease with various phenotypes, but their onset and stability remain poorly understood due to limited longitudinal data.
Phenotypes describe clinical features but don't fully explain underlying causes (etiology and pathophysiology).
Different disease mechanisms (endotypes) can manifest as similar asthma symptoms, necessitating a deeper understanding beyond clinical presentation.

Purpose of the Study:

To highlight the importance of distinguishing asthma phenotypes based on disease severity and duration.
To introduce the concept of endotypes as distinct pathogenic mechanisms underlying asthma phenotypes.
To emphasize the need for linking endotypes with phenotypes through molecular biomarkers for improved classification and treatment.

Main Methods:

Review of current understanding of asthma phenotypes and endotypes.
Discussion on the potential of endotype classification for epidemiological, genetic, and drug-related research.
Emphasis on the requirement for longitudinal studies to validate endotype stability and predictive power.

Main Results:

Endotypes represent underlying pathogenetic mechanisms, offering advantages over phenotype-based classification.
Identifying molecular biomarkers is key to linking specific mechanisms to phenotypes or subgroups.
Accurate endotyping is expected to reflect the natural history of asthma and predict treatment response.

Conclusions:

Endotype classification provides a more precise approach to understanding and managing asthma.
Linking molecular biomarkers to endotypes is essential for personalized asthma care.
Further longitudinal studies are required to validate the predictive value of asthma endotypes in clinical practice.